Expression of genes encoding antimicrobial proteins and members of the toll-like receptor/nuclear factor-κB pathways in engineered human skin

Wound Repair and Regeneration

Volumn 16, Issue 4, 2008, Pages 534-541

  McFarland, Kevin L ^a   Klingenberg, Jennifer M ^a   Boyce, Steven T ^a,b   Supp, Dorothy M ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CATHELICIDIN; CYTOKINE; DEFENSIN 1; DEFENSIN 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; POLYPEPTIDE ANTIBIOTIC AGENT; S100A12; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; UPREGULATION;

BETA-DEFENSINS; BLOTTING, NORTHERN; CYTOKINES; FIBROBLASTS; GENE EXPRESSION; HUMANS; KERATINOCYTES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TISSUE ENGINEERING; TOLL-LIKE RECEPTORS;

EID: 47349090750     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2008.00401.x     Document Type: Article

References (44)

1. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000 1:141 50.
2. Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG. Expression of natural peptide antibiotics in human skin. Lancet 1997 350:1750 1.
3. Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 2001 117:106 11.
4. Ganz T, Lehrer RI. Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today 1999 5:292 7.
5. Yang D, Chertov OBSN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder J-M, Wang JM, Howard OMZ, Oppenheim JJ. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999 286:525 8.
6. Kopp E, Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol 2003 15:396 401.
7. McInturff JE, Modlin RL, Kim J. The role of Toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2004 125:1 8.
8. Pivarcsi A, Bodai L, Réthi B, Kenderessy-Szabó A, Koreck A, Széll M, Beer Z, Bata-Csörgõ Z, Magócsi M, Rajnavölgyi E, Dobozy A, Kemény L. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003 15:721 30.
9. Sumikawa Y, Asada H, Hoshino K, Azukizawa H, Katayama I, Akira S, Itami S. Induction of β-defensin 3 in keratinocytes stimulated by bacterial lipopeptides through toll-like receptor 2. Microbes Infect 2006 8:1513 21.
10. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defense. Nat Rev Immunol 2007 7:179 90.
11. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004 12:44 9.
12. Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu TT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zügel U, Bikle DD, Modlin RL, Gallo RL. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007 117:803 11.
13. Supp DM, Karpinski AK, Boyce ST. Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes. Burns 2004 30:643 8.
14. Boyce ST, Kagan RJ, Greenhalgh DG, Warner P, Yakuboff KP, Palmieri T, Warden GD. Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma 2006 60:821 9.
15. Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP, Warden GD. The 1999 Clinical Research Award. Cultured skin substitutes combined with Integra to replace native skin autograft and allograft for closure of full-thickness burns. J Burn Care Rehabil 1999 20:453 61.
16. Boyce ST, Kagan RJ, Yakuboff KP, Meyer NA, Rieman MT, Greenhalgh DG, Warden GD. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 2002 235:269 79.
17. Passaretti D, Billmire D, Kagan R, Corcoran J, Boyce S. Autologous cultured skin substitutes conserve donor site autograft in elective treatment of congenital giant melanocyte nevus. Plast Reconstr Surg 2004 114:1523 8.
18. Boyce ST, Glatter R, Kitzmiller WJ. Treatment of chronic wounds with cultured cells and biopolymers: a pilot study. Wounds 1995 7:24 9.
19. Boyce ST, Supp AP, Harriger MD, Greenhalgh DG, Warden GD. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J Invest Dermatol 1995 104:345 9.
20. Boyce ST, Warden GD, Holder IA. Non-cytotoxic combinations of topical antimicrobial agents for use with cultured skin. Antimicrob Agents Chemother 1995 39:1324 8.
21. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 2002 118:275 81.
22. Harder J, Bartels J, Christophers E, Schroder J-M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001 276:5707 13.
23. Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, Gudmundsson GH. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997 272:15258 63.
24. Li J, Li D, Tan Z. The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 in patients with psoriasis vulgaris. J Huazhong Univ Sci Technol Med Sci 2004 24:294 6.
25. Liang SC, Tan X-Y, Luxenberg DP, Karin R, Dunussi-Joannopoulos K, Collins M, Fouser lA. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006 203:2271 9.
26. Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 2004 173:3482 91.
27. Boyce ST, Ham RG. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media. J Tiss Culture Methods 1985 9:83 93.
28. Boyce ST. Methods for the serum-free culture of keratinocytes and transplantation of collagen-GAG-based skin substitutes. In:Morgan JR, Yarmush ML, editors. Methods in molecular medicine, vol. 18: tissue engineering methods and protocols. Totowa, NJ:Humana Press Inc., 1999:365 89.
29. Boyce ST, Christianson DJ, Hansbrough JF. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res 1988 22:939 57.
30. Boyce ST, Supp AP, Swope VB, Warden GD. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane formation in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol 2002 118:565 72.
31. Boyce ST, Supp AP, Harriger MD, Pickens WL, Wickett RR, Hoath SB. Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice. J Invest Dermatol 1996 107:82 7.
32. ΔΔCT method. Methods 2001 25:402 8.
33. Mori K, Stone S, Khaodhiar L, Braverman LE, DeVito WJ. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. J Cell Biol 1999 74:211 9.
34. Tamamura H, Fujii R. The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. Exp Opin Ther Targets 2005 9:1267 82.
35. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002 417:552 5.
36. Weinberg ED. Human lactoferrin: a novel therapeutic with broad spectrum potential. J Pharm Pharmacol 2001 53:1303 10.
37. Zweiman B, Kucich U, Shalit M, Von Allmen C, Moskovitz A, Weinbaum G, Atkins PC. Release of lactoferrin and elastase in human allergic skin reactions. J Immunol 1990 144:3953 60.
38. Cellier M, Govoni G, Vidal S, Kwan T, Groulx N, Liu J, Sanchez F, Skamene E, Schurr E, Gros P. Human natural resistance-associate macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 1994 180:1741 52.
39. Timms AE, Crane AM, Sims AM, Cordell HJ, Bradbury LA, Abbott A, Coyne MR, Beynon O, Herzberg I, Duff GW, Calin A, Cardon LR, Wordsworth BP, Brown MA. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004 75:587 95.
40. Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C, Gladman D. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006 54:2321 5.
41. Smiley AK, Klingenberg JM, Aronow BJ, Boyce ST, Kitzmiller WJ, Supp DM. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J Invest Dermatol 2005 125:1286 301.
42. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005 125:9 13.
43. Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol 2005 21:357 74.
44. Meyer T, Stockfleth E, Christophers E. Immune response profiles in human skin. Br J Dermatol 2007 157 (Suppl. 2):1 7.